TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases (2021)

First Author: Luchner M
Attributed to:  Liverpool School of Tropical Medicine Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics13020142

PubMed Identifier: 33499143

Publication URI: http://europepmc.org/abstract/MED/33499143

Type: Journal Article/Review

Parent Publication: Pharmaceutics

Issue: 2

ISSN: 1999-4923